Nuvo Pharmaceuticals Inc
TSX:MRV

Watchlist Manager
Nuvo Pharmaceuticals Inc Logo
Nuvo Pharmaceuticals Inc
TSX:MRV
Watchlist
Price: 1.35 CAD Market Closed
Market Cap: 15.4m CAD

Intrinsic Value

MRV doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of MRV.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRV Intrinsic Value
Not Available
Base Case Scenario
Compare MRV to

Fundamental Analysis

Nuvo Pharmaceuticals Inc
TSX:MRV
CA
Pharmaceuticals
Market Cap
15.4m CAD
IPO
Aug 22, 1983
CA
Pharmaceuticals
Market Cap
15.4m CAD
IPO
Aug 22, 1983
Price
CA$
CA$
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MRV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nuvo Pharmaceuticals Inc

Current Assets 51.8m
Cash & Short-Term Investments 31.3m
Receivables 10.1m
Other Current Assets 10.5m
Non-Current Assets 75.4m
PP&E 3.8m
Intangibles 71.7m
Current Liabilities 24.6m
Accounts Payable 10.4m
Other Current Liabilities 14.2m
Non-Current Liabilities 94.2m
Long-Term Debt 86.1m
Other Non-Current Liabilities 8m
Efficiency

Free Cash Flow Analysis
Nuvo Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nuvo Pharmaceuticals Inc

Revenue
72.4m CAD
Cost of Revenue
-27.4m CAD
Gross Profit
45.1m CAD
Operating Expenses
-32.6m CAD
Operating Income
12.4m CAD
Other Expenses
2.8m CAD
Net Income
15.2m CAD
Fundamental Scores

MRV Profitability Score
Profitability Due Diligence

Nuvo Pharmaceuticals Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
Exceptional Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Gross Margin
55/100
Profitability
Score

Nuvo Pharmaceuticals Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

MRV Solvency Score
Solvency Due Diligence

Nuvo Pharmaceuticals Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
High D/E
25/100
Solvency
Score

Nuvo Pharmaceuticals Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRV Price Targets Summary
Nuvo Pharmaceuticals Inc

There are no price targets for MRV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MRV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y